羟基氯喹
免疫系统
肾病
体内
免疫学
医学
菌群(微生物学)
生物
微生物学
内科学
疾病
细菌
内分泌学
糖尿病
生物技术
2019年冠状病毒病(COVID-19)
传染病(医学专业)
遗传学
作者
Chaochao Wang,Xiaoqiao Cai,Shengfen Lin,Yongqiang Lin
标识
DOI:10.1080/08923973.2023.2300306
摘要
BACKGROUND: experiments. METHODS: cellular model of IgAN. At the end of experimental period, samples were collected for further analysis. RESULTS: Treg in the IgAN group was effectively reversed by HCQ. Furthermore, HCQ has the capacity to restore the compromised state of the intestinal mucosal barrier induced by IgAN and mitigate the circumstances of intestinal permeability and disruption in the intestinal flora. CONCLUSION: HCQ diminishes IgA aberrant glycosylation levels, ameliorates renal and intestinal histopathological damage, and attenuates intestinal flora disorders and immune dysfunction in IgAN rats by means of activating the C1GALT1/Cosmc pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI